Decibel Bio develops an epigenetic reprogramming platform to enhance plant resilience and improve crop yield under environmental stresses.

eGenesis is a biotechnology company developing genetically engineered organs to address the global organ shortage, with a focus on advancing their lead product candidate for kidney transplants.

Deka Biosciences is a biotech company that aims to improve immunotherapy treatments by combining biology with precision medicine, specifically through their investigational new drug, DK210 (EGFR), which has dissociated IL-2 potency from toxicity.

ReCode Therapeutics is a genetic medicines company that uses precision delivery to develop mRNA and gene correction therapeutics, with a focus on treatments for primary ciliary dyskinesia, cystic fibrosis, and other genetic diseases.